303 related articles for article (PubMed ID: 28357571)
1. Predicting Treatment Response of Colorectal Cancer Liver Metastases to Conventional Lipiodol-Based Transarterial Chemoembolization Using Diffusion-Weighted MR Imaging: Value of Pretreatment Apparent Diffusion Coefficients (ADC) and ADC Changes Under Therapy.
Lahrsow M; Albrecht MH; Bickford MW; Vogl TJ
Cardiovasc Intervent Radiol; 2017 Jun; 40(6):852-859. PubMed ID: 28357571
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization.
Schmeel FC; Simon B; Luetkens JA; Träber F; Meyer C; Schmeel LC; Sabet A; Ezziddin S; Schild HH; Hadizadeh DR
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1531-1541. PubMed ID: 28317063
[TBL] [Abstract][Full Text] [Related]
3. [Water mobility of diffusion MRI in prediction of response to chemoembolization in liver cancer].
Yuan Z; Ye XD; Dong S; Xu LC; Sun ZC; Xiao XS
Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):293-7. PubMed ID: 19615287
[TBL] [Abstract][Full Text] [Related]
4. Survival of patients with non-resectable, chemotherapy-resistant colorectal cancer liver metastases undergoing conventional lipiodol-based transarterial chemoembolization (cTACE) palliatively versus neoadjuvantly prior to percutaneous thermal ablation.
Vogl TJ; Lahrsow M; Albrecht MH; Hammerstingl R; Thompson ZM; Gruber-Rouh T
Eur J Radiol; 2018 May; 102():138-145. PubMed ID: 29685527
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of treatment response of chemoembolization in hepatocellular carcinoma with diffusion-weighted imaging on 3.0-T MR imaging.
Sahin H; Harman M; Cinar C; Bozkaya H; Parildar M; Elmas N
J Vasc Interv Radiol; 2012 Feb; 23(2):241-7. PubMed ID: 22019180
[TBL] [Abstract][Full Text] [Related]
6. Role of magnetic resonance diffusion-weighted imaging in evaluating response after chemoembolization of hepatocellular carcinoma.
Yuan Z; Ye XD; Dong S; Xu LC; Xu XY; Liu SY; Xiao XS
Eur J Radiol; 2010 Jul; 75(1):e9-14. PubMed ID: 19540083
[TBL] [Abstract][Full Text] [Related]
7. Diffusion-weighted and hepatobiliary phase gadoxetic acid-enhanced quantitative MR imaging for identification of complete pathologic response in colorectal liver metastases after preoperative chemotherapy.
Hosseini-Nik H; Fischer SE; Moulton CA; Karbhase G; Menezes RJ; Gallinger S; Jhaveri KS
Abdom Radiol (NY); 2016 Feb; 41(2):231-8. PubMed ID: 26867904
[TBL] [Abstract][Full Text] [Related]
8. Islet cell liver metastases: assessment of volumetric early response with functional MR imaging after transarterial chemoembolization.
Li Z; Bonekamp S; Halappa VG; Corona-Villalobos CP; Pawlik T; Bhagat N; Reyes D; Lai H; Geschwind JF; Kamel IR
Radiology; 2012 Jul; 264(1):97-109. PubMed ID: 22627602
[TBL] [Abstract][Full Text] [Related]
9. Transarterial chemoembolization of colorectal cancer liver metastasis: improved tumor response by DSM-TACE versus conventional TACE, a prospective, randomized, single-center trial.
Vogl TJ; Marko C; Langenbach MC; Naguib NNN; Filmann N; Hammerstingl R; Gruber-Rouh T
Eur Radiol; 2021 Apr; 31(4):2242-2251. PubMed ID: 32960329
[TBL] [Abstract][Full Text] [Related]
10. 3T diffusion-weighted MRI in the response assessment of colorectal liver metastases after chemotherapy: Correlation between ADC value and histological tumour regression grading.
Donati F; Boraschi P; Pacciardi F; Cervelli R; Castagna M; Urbani L; Falaschi F; Caramella D
Eur J Radiol; 2017 Jun; 91():57-65. PubMed ID: 28629572
[TBL] [Abstract][Full Text] [Related]
11. Baseline 3D-ADC outperforms 2D-ADC in predicting response to treatment in patients with colorectal liver metastases.
Fouladi DF; Zarghampour M; Pandey P; Pandey A; Varzaneh FN; Ghasabeh MA; Khoshpouri P; Kamel IR
Eur Radiol; 2020 Jan; 30(1):291-300. PubMed ID: 31209620
[TBL] [Abstract][Full Text] [Related]
12. Predicting early necrosis of colorectal liver metastases using volumetric enhancement on baseline MRI and oil deposition on post-cTACE unenhanced CT.
Hazhirkarzar B; Tang H; Ghadimi M; Baghdadi A; Motaghi M; Wu Q; Shaghaghi M; Kamel I
Abdom Radiol (NY); 2021 Oct; 46(10):4610-4618. PubMed ID: 34089068
[TBL] [Abstract][Full Text] [Related]
13. Transarterial chemoembolization in pancreatic adenocarcinoma with liver metastases: MR-based tumor response evaluation, apparent diffusion coefficient (ADC) patterns, and survival rates.
Vogl TJ; Mohamed SA; Albrecht MH; Gruber-Roh T; Lin H; Nour Eldin NEA; Bednarova I; Naguib NN; Panahi B
Pancreatology; 2018 Jan; 18(1):94-99. PubMed ID: 29221632
[TBL] [Abstract][Full Text] [Related]
14. Diffusion-Weighted MR Imaging of Primary and Secondary Lung Cancer: Predictive Value for Response to Transpulmonary Chemoembolization and Transarterial Chemoperfusion.
Vogl TJ; Hoppe AT; Gruber-Rouh T; Basten L; Dewes P; Hammerstingl RM; Balaban Ü; Mastrodicasa D; Thompson ZM; Albrecht MH
J Vasc Interv Radiol; 2020 Feb; 31(2):301-310. PubMed ID: 31899107
[TBL] [Abstract][Full Text] [Related]
15. Liver metastases from colorectal cancer treated with conventional and antiangiogenetic chemotherapy: evaluation with liver computed tomography perfusion and magnetic resonance diffusion-weighted imaging.
Anzidei M; Napoli A; Zaccagna F; Cartocci G; Saba L; Menichini G; Cavallo Marincola B; Marotta E; Di Mare L; Catalano C; Passariello R
J Comput Assist Tomogr; 2011; 35(6):690-6. PubMed ID: 22082538
[TBL] [Abstract][Full Text] [Related]
16. Baseline and Early MR Apparent Diffusion Coefficient Quantification as a Predictor of Response of Unresectable Hepatocellular Carcinoma to Doxorubicin Drug-Eluting Bead Chemoembolization.
Kokabi N; Ludwig JM; Camacho JC; Xing M; Mittal PK; Kim HS
J Vasc Interv Radiol; 2015 Dec; 26(12):1777-86. PubMed ID: 26603497
[TBL] [Abstract][Full Text] [Related]
17. Equivalent cross-relaxation rate imaging and diffusion weighted imaging for early prediction of response to bevacizumab-containing treatment in colorectal liver metastases-preliminary study.
Matsushima S; Sato T; Nishiofuku H; Sato Y; Murata S; Kinosada Y; Era S; Inaba Y
Clin Imaging; 2017; 41():1-6. PubMed ID: 27721090
[TBL] [Abstract][Full Text] [Related]
18. Relationship of apparent diffusion coefficient to survival for patients with unresectable primary hepatocellular carcinoma after chemoembolization.
Dong S; Ye XD; Yuan Z; Xu LC; Xiao XS
Eur J Radiol; 2012 Mar; 81(3):472-7. PubMed ID: 21296517
[TBL] [Abstract][Full Text] [Related]
19. Immediate post-doxorubicin drug-eluting beads chemoembolization Mr Apparent diffusion coefficient quantification predicts response in unresectable hepatocellular carcinoma: A pilot study.
Kokabi N; Camacho JC; Xing M; Edalat F; Mittal PK; Kim HS
J Magn Reson Imaging; 2015 Oct; 42(4):981-9. PubMed ID: 25683022
[TBL] [Abstract][Full Text] [Related]
20. Multimodality imaging to predict response to systemic treatment in patients with advanced colorectal cancer.
Heijmen L; ter Voert EE; Oyen WJ; Punt CJ; van Spronsen DJ; Heerschap A; de Geus-Oei LF; van Laarhoven HW
PLoS One; 2015; 10(4):e0120823. PubMed ID: 25831053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
